company background image
CHOO

Choom Holdings CNSX:CHOO Stock Report

Last Price

CA$0.005

Market Cap

CA$2.3m

7D

0%

1Y

-93.3%

Updated

24 Jun, 2022

Data

Company Financials
CHOO fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

CHOO Stock Overview

Choom Holdings Inc., together with its subsidiaries, engages in the retail of cannabis.

Choom Holdings Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for Choom Holdings
Historical stock prices
Current Share PriceCA$0.005
52 Week HighCA$0.08
52 Week LowCA$0.005
Beta1.11
1 Month Change0%
3 Month Change-66.67%
1 Year Change-93.33%
3 Year Change-98.88%
5 Year Change-97.06%
Change since IPO-98.57%

Recent News & Updates

Dec 01
Is Choom Holdings (CSE:CHOO) A Risky Investment?

Is Choom Holdings (CSE:CHOO) A Risky Investment?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Shareholder Returns

CHOOCA PharmaceuticalsCA Market
7D0%-0.3%0.3%
1Y-93.3%-70.9%-4.1%

Return vs Industry: CHOO underperformed the Canadian Pharmaceuticals industry which returned -71.6% over the past year.

Return vs Market: CHOO underperformed the Canadian Market which returned -5.7% over the past year.

Price Volatility

Is CHOO's price volatile compared to industry and market?
CHOO volatility
CHOO Average Weekly Movement35.6%
Pharmaceuticals Industry Average Movement11.8%
Market Average Movement9.9%
10% most volatile stocks in CA Market17.2%
10% least volatile stocks in CA Market4.3%

Stable Share Price: CHOO is more volatile than 90% of Canadian stocks over the past 3 months, typically moving +/- 36% a week.

Volatility Over Time: CHOO's weekly volatility has increased from 23% to 36% over the past year.

About the Company

FoundedEmployeesCEOWebsite
200670Corey Gillonhttps://choomholdings.ca

Choom Holdings Inc., together with its subsidiaries, engages in the retail of cannabis. It sells cannabis products and accessories. The company’s cannabis accessories include rolling papers, holders, pipes, water pipes, bongs, vaporizers, and other things used to consume cannabis.

Choom Holdings Fundamentals Summary

How do Choom Holdings's earnings and revenue compare to its market cap?
CHOO fundamental statistics
Market CapCA$2.33m
Earnings (TTM)-CA$16.02m
Revenue (TTM)CA$19.04m

0.1x

P/S Ratio

-0.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CHOO income statement (TTM)
RevenueCA$19.04m
Cost of RevenueCA$11.86m
Gross ProfitCA$7.19m
Other ExpensesCA$23.20m
Earnings-CA$16.02m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.034
Gross Margin37.74%
Net Profit Margin-84.11%
Debt/Equity Ratio-343.0%

How did CHOO perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is CHOO undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CHOO?

Other financial metrics that can be useful for relative valuation.

CHOO key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1x
Enterprise Value/EBITDA-6.8x
PEG Ration/a

Price to Sales Ratio vs Peers

How does CHOO's PS Ratio compare to its peers?

CHOO PS Ratio vs Peers
The above table shows the PS ratio for CHOO vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average3.1x

Price-To-Sales vs Peers: CHOO is good value based on its Price-To-Sales Ratio (0.1x) compared to the peer average (3.1x).


Price to Earnings Ratio vs Industry

How does CHOO's PE Ratio compare vs other companies in the Canadian Pharmaceuticals Industry?

Price-To-Sales vs Industry: CHOO is good value based on its Price-To-Sales Ratio (0.1x) compared to the Canadian Pharmaceuticals industry average (1.9x)


Price to Sales Ratio vs Fair Ratio

What is CHOO's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CHOO PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.1x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate CHOO's Price-To-Sales Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of CHOO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate CHOO's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate CHOO's fair value for valuation analysis.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate CHOO's PEG Ratio to determine if it is good value.


Discover undervalued companies

  • Take a look at our analysis of CHOO's management and see if the CEO's compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don't know where to start, we recommend reading through Choom Holdings regulatory filings.

Future Growth

How is Choom Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


72.2%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Choom Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Discover growth companies

  • Take a look at our analysis of CHOO’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • Choom Holdings competitive advantages and company strategy can generally be found in its financial reports archived here.

Past Performance

How has Choom Holdings performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-38.1%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: CHOO is currently unprofitable.

Growing Profit Margin: CHOO is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: CHOO is unprofitable, and losses have increased over the past 5 years at a rate of 38.1% per year.

Accelerating Growth: Unable to compare CHOO's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CHOO is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (118.1%).


Return on Equity

High ROE: CHOO's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Discover strong past performing companies

Financial Health

How is Choom Holdings's financial position?

Financial Health Score

0/6

Financial Health Score 0/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: CHOO has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: CHOO has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: CHOO has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: CHOO's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: CHOO has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: CHOO has less than a year of cash runway if free cash flow continues to reduce at historical rates of 18.5% each year


Discover healthy companies

Dividend

What is Choom Holdings's current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate CHOO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate CHOO's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if CHOO's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CHOO's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as CHOO has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

2.6yrs

Average management tenure


CEO

Corey Gillon

2.5yrs

Tenure

CA$246,902

Compensation

Mr. Corey Gillon has been Chief Executive Officer of Choom Holdings Inc. since December 1, 2019 and serves as its Director since 2021. He served as President of Choom Holdings Inc. since August 26, 2019 un...


CEO Compensation Analysis

Compensation vs Market: Insufficient data to establish whether Corey's total compensation is reasonable compared to companies of similar size in the Canadian market.

Compensation vs Earnings: Insufficient data to compare Corey's compensation with company performance.


Leadership Team

Experienced Management: CHOO's management team is considered experienced (2.6 years average tenure).


Board Members

Experienced Board: CHOO's board of directors are considered experienced (4.1 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 43.6%.


Top Shareholders

Company Information

Choom Holdings Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Choom Holdings Inc.
  • Ticker: CHOO
  • Exchange: CNSX
  • Founded: 2006
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: CA$2.335m
  • Shares outstanding: 466.97m
  • Website: https://choomholdings.ca

Number of Employees


Location

  • Choom Holdings Inc.
  • 1525 West 8th Avenue
  • Suite 208
  • Vancouver
  • British Columbia
  • V6J 1T5
  • Canada

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/06/24 00:00
End of Day Share Price2022/06/06 00:00
Earnings2021/12/31
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.